Skip to content
Thursday, November 19, 2026
BizInsight

Zimbabwe Turns Down ‘Lopsided’ US Health Aid Deal Because of Information Fears

Medical aid image
The proposed American funding would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to Washington's insistence on sensitive data.

This rejection was revealed following a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa felt the deal was "unbalanced".

An official spokesperson has since explained that the United States was requesting health data for research and commercial purposes but was not willing to guarantee the resulting advantages from future vaccines.

"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged continued dialogue to find a agreement acceptable to all parties so the nation's vital HIV treatment initiative can be sustained.

Wider Implications

Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US following concerns were raised about the security of Kenyans' medical information.

After resuming office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

The agency had administered assistance for the American government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and accountability.

According to reports, Sixteen nations in Africa have to date agreed to similar agreements, representing over $18.3bn of fresh investment.

Specifics of the Declined Deal

The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported programmes," Tremont added.

However, official spokesman Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to share its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.

"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our citizens if a future health crisis emerge."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems already set up through the global organization.

Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with future pandemics.

"This mechanism is intended to ensure that when a nation provides its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."

These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how future co-operation could be structured in a way that respects the independence and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that negotiations must proceed given that a large portion of the country's HIV programmes were funded by foreign aid.

"In cases where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it said.

The situation highlights the ongoing challenges between receiving vital foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.

Written by

Brenda Bowen

A seasoned financial analyst with over 15 years of experience in Middle Eastern markets, specializing in economic forecasting and investment strategies.

BizInsight

Type to search articles.